Literature DB >> 15621728

Heparin-binding epidermal growth factor-like growth factor (HB-EGF) is a mediator of multiple physiological and pathological pathways.

Eiichiro Nishi1, Michael Klagsbrun.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15621728     DOI: 10.1080/08977190400008448

Source DB:  PubMed          Journal:  Growth Factors        ISSN: 0897-7194            Impact factor:   2.511


× No keyword cloud information.
  20 in total

1.  A role for the epidermal growth factor receptor signaling in development of intestinal serrated polyps in mice and humans.

Authors:  Gerold Bongers; Luciana R Muniz; Michelle E Pacer; Alina C Iuga; Nanthakumar Thirunarayanan; Erik Slinger; Martine J Smit; E Premkumar Reddy; Lloyd Mayer; Glaucia C Furtado; Noam Harpaz; Sergio A Lira
Journal:  Gastroenterology       Date:  2012-05-26       Impact factor: 22.682

2.  Enhancement of trophoblast differentiation and survival by low molecular weight heparin requires heparin-binding EGF-like growth factor.

Authors:  Alan D Bolnick; Jay M Bolnick; Hamid-Reza Kohan-Ghadr; Brian A Kilburn; Omar J Pasalodos; Pankaj K Singhal; Jing Dai; Michael P Diamond; D Randall Armant; Sascha Drewlo
Journal:  Hum Reprod       Date:  2017-06-01       Impact factor: 6.918

Review 3.  Heparin-Binding Epidermal Growth Factor-Like Growth Factor as a Critical Mediator of Tissue Repair and Regeneration.

Authors:  Duy T Dao; Lorenzo Anez-Bustillos; Rosalyn M Adam; Mark Puder; Diane R Bielenberg
Journal:  Am J Pathol       Date:  2018-08-22       Impact factor: 4.307

4.  Nanoglycan complex formulation extends VEGF retention time in the lung.

Authors:  E Hunter Lauten; Jarod VerBerkmoes; Justin Choi; Richard Jin; David A Edwards; Joseph Loscalzo; Ying-Yi Zhang
Journal:  Biomacromolecules       Date:  2010-07-12       Impact factor: 6.988

5.  HB-EGF improves intestinal microcirculation after hemorrhagic shock.

Authors:  Hong-yi Zhang; Andrei Radulescu; Yan Chen; Gail E Besner
Journal:  J Surg Res       Date:  2010-02-11       Impact factor: 2.192

6.  Activation of EGFR by proteasome inhibition requires HB-EGF in pancreatic cancer cells.

Authors:  C M Sloss; F Wang; M A Palladino; J C Cusack
Journal:  Oncogene       Date:  2010-03-08       Impact factor: 9.867

7.  Amino-terminal deletion of heparin-binding epidermal growth factor-like growth factor4-127 stimulates cell proliferation but lacks insulin-like activity.

Authors:  Z Zhou; P A Harding
Journal:  Cell Prolif       Date:  2007-04       Impact factor: 6.831

8.  Heparin-binding epidermal growth factor-like growth factor is essential for preservation of gut barrier function after hemorrhagic shock and resuscitation in mice.

Authors:  Hong-Yi Zhang; Andrei Radulescu; Gail E Besner
Journal:  Surgery       Date:  2009-08       Impact factor: 3.982

Review 9.  HB-EGF: a unique mediator of embryo-uterine interactions during implantation.

Authors:  Hyunjung Jade Lim; S K Dey
Journal:  Exp Cell Res       Date:  2008-08-03       Impact factor: 3.905

10.  Epidermal growth factor-like growth factors prevent apoptosis of alcohol-exposed human placental cytotrophoblast cells.

Authors:  Garen S Wolff; Po Jen Chiang; Susan M Smith; Roberto Romero; D Randall Armant
Journal:  Biol Reprod       Date:  2007-03-28       Impact factor: 4.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.